Opioid-induced constipation Trials in Winston-Salem, United States
Conditions / Opioid-induced constipation / Winston-Salem, United States
Clinical trials for Opioid-induced constipation investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01965652 | Long Term Safety of Naldemedine | COMPLETED | PHASE3 |
| NCT00672139 | Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness | COMPLETED | PHASE4 |
| NCT01965158 | Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation | COMPLETED | PHASE3 |
| NCT01993940 | Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation | COMPLETED | PHASE3 |
| NCT00399659 | Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. | TERMINATED | PHASE3 |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | TERMINATED | PHASE3 |
| NCT02270983 | Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain | COMPLETED | PHASE2 |
| NCT00672477 | Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness | COMPLETED | PHASE4 |
| NCT03060512 | To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation | COMPLETED | PHASE4 |
| NCT01443403 | A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy | COMPLETED | PHASE2 |